You Position: Home > Paper

Anti-virus combined with autologous bone marrow stem cell transplantation for treatment of decompensated cirrhosis

( views:0, downloads:0 )
Author:
No author available
Journal Title:
China Clinical Practical Medicine
Issue:
1
DOI:
10.3760/cma.j.issn.1673-8799.2014.01.008
Key Word:
恩替卡韦;自体骨髓干细胞移植;乙肝肝硬化失代偿期;Entecavir;Autologous bone marrow stem cell transplantation;Decompensated liver cirrhosis

Abstract´╝Ü Objective Analysis of entecavir combined with autologous bone marrow stem cell transplantation on the treatment of patients with liver cirrhosis.Methods Select decompensated liver cirrhosis 78 patients.From the patient's bone marrow posterior superior iliac spine,Purification of in vitro bone marrow-derived stem cells,Through the femoral artery puncture implanted liver.After surgery in patients 2,4,8 weeks to check the relevant laboratory parameters.Results Our first four weeks after surgery and eight weeks found that most patients with clinical signs and symptoms have markedly improved,Ascites reduce or mitigate the total 68 cases and 72 cases,fatigue symptoms improved with 69 cases and 75 cases,reduce bloating in patients with 69 cases and 72 cases.We found that in the first four weeks after surgery,a number of indicators have been significant changes,ALT,AST,TBIL decreased,ALB,PT% improved significantly.Conclusion BMSC transplantation in liver itself is a significant advancement of clinical treatment and beneficial supplement BMSC liver transplantation to patients a new choice.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn